Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs →
glpzoom

Do I qualify for Wegovy?

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Wegovy is FDA-approved for adults with a BMI of 30 or greater, or BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea. It is also approved for adolescents aged 12 and older at or above the 95th percentile BMI for age and sex. Contraindications include personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Patients with active pancreatitis, severe gastroparesis, or pregnancy/breastfeeding should not start Wegovy. Use of GLP-1 medications around the time of surgery requires special anesthesia precautions.

Where to start

Licensed US telehealth services that handle this. We may earn a commission when you sign up. See disclosure.

  • Ro logo

    Ro

    from $145/mo
    • Best for insured patients
    • Best for clinical oversight

    Ro Body — branded GLP-1 weight care program

    Visit Ro →Read review
  • Hims logo

    Hims

    from $199/mo
    • Best for cash-pay
    • Best for speed

    Hims Weight Loss — compounded GLP-1 from $199/mo

    Visit Hims →Read review
  • Noom Med logo

    Noom Med

    from $179/mo
    • Best for coaching
    • Best for maintenance

    Noom Med — GLP-1 + behavioral psychology coaching

    Visit Noom Med →Read review

Drugs referenced

Related questions

  • How can I get Wegovy online?

    Several licensed telehealth services prescribe Wegovy through online intake and asynchronous (or live) clinician evaluation. The typical path: (1) complete a medical intake form including height, weight, conditions, and history; (2) a licensed clinician in your state reviews and either prescribes, requests more info, or declines; (3) prescription is routed t

  • What are the most common Wegovy side effects?

    The most common Wegovy side effects are gastrointestinal: nausea (40-44% of trial patients), diarrhea (30%), vomiting (24%), and constipation (24%). These typically peak during dose escalation in the first 4-8 weeks and improve as the body adapts. Less common but serious risks include gallbladder problems, pancreatitis, kidney strain (especially if dehydrate

We may earn a commission when you click links to partners. Affiliate disclosure.